Fund Holdings — Medicxi Ventures Management (Jersey) Ltd

Total Portfolio Value:
$296.23M
Total Bought:
$0
Total Sold:
$53.52M
Net Transaction:
-$53.52M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Centessa Pharmaceuticals PlcADS19,963,15719,963,1570$129.16M$158.91M53.64%+$29.75M
Merus N V1,600,0001,600,0000$37.73M$44.00M14.85%+$6.27M
Phathom Pharmaceuticals, Inc.(PHAT)3,760,8693,760,8690$39.00M$34.34M11.59%-$4.66M
Newamsterdam Pharma Company
ORDINARY SHARES
2,869,5652,869,5650$26.54M$32.05M10.82%+$5.51M
Aura Biosciences, Inc.(AURA)3,039,8923,039,8920$27.27M$26.93M9.09%-$334.4K
VAXCYTE INCCOM(PCVX)1,049,8930-1,049,893$53.52M$0—-$53.52M
Page 1 of 1
Medicxi Ventures Management (Jersey) Ltd — 13F Holdings — Q4 2023 | TickerTrail